Zoekresultaten - Jon Strasser

  • Toon 1 - 5 resultaten van 5
Verfijn jouw resultaten
  1. 1
    Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation

    Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation door Shira Galper, James B. Yu, Peter Mauch, Jon Strasser, Barbara Silver, Ann S. LaCasce, Karen J. Marcus, Mary Ann Stevenson, Ming Hui Chen, Andrea K. Ng

    Gepubliceerd in 2010
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial

    Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial door Julie Ryan Wolf, Jennifer S. Gewandter, Javier Bautista, Charles E. Heckler, Jon Strasser, Pawal Dyk, Thomas Anderson, Howard M. Gross, Tod W. Speer, Lindsey B Dolohanty, Kevin Bylund, Alice P. Pentland, Gary R. Morrow

    Gepubliceerd in 2019
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population

    Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population door Jennifer J. Hu, James J. Urbanic, L. D. Case, Cristiane Takita, Jean L. Wright, Doris Brown, Carl D. Langefeld, Mark O. Lively, Sandra E. Mitchell, Anu Thakrar, David Bryant, Kathy Baglan, Jon Strasser, Luis Báez-Díaz, Glenn J. Lesser, Edward G. Shaw

    Gepubliceerd in 2018
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424

    Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424 door Barbara J. Fisher, Stephanie L. Pugh, David Macdonald, Arnab Chakravatri, Glenn J. Lesser, Sherry Fox, Leland Rogers, Maria Werner‐Wasik, Thomas J. Doyle, Jean-Paul Bahary, John B. Fiveash, Joseph Bovi, Steven Howard, Ya-Yu Tsai, David D’Souza, Nadia N. Laack, Igor J. Barani, Young Kwok, Daniel Wahl, Jon Strasser, Minhee Won, Minesh P. Mehta

    Gepubliceerd in 2020
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

    Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer door Ethan Basch, Deborah Schrag, Sydney Henson, Jennifer Jansen, Brenda Ginos, Angela M. Stover, Philip Carr, Patricia A. Spears, Mattias Jönsson, Allison M. Deal, Antonia V. Bennett, Gita Thanarajasingam, Lauren J. Rogak, Bryce B. Reeve, Claire Snyder, Deborah Watkins Bruner, David Cella, Lisa A. Kottschade, Jane Perlmutter, Cindy Geoghegan, Cleo A. Samuel, Barbara Given, Gina L. Mazza, Robert S. Miller, Jon Strasser, Dylan M. Zylla, Anna Weiss, Victoria Blinder, Amylou C. Dueck

    Gepubliceerd in 2022
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: